Target	Disease	Drug_index	Drug
EGFR	Non-Small Cell Lung Carcinoma	1	afatinib dimaleate [Epidermal growth factor receptor erbB1 inhibitor], amivantamab [Epidermal growth factor receptor inhibitor], brigatinib [Epidermal growth factor receptor erbB1 inhibitor], dacomitinib [Epidermal growth factor receptor erbB1 inhibitor], erlotinib hydrochloride [Epidermal growth factor receptor erbB1 inhibitor], gefitinib [Epidermal growth factor receptor erbB1 inhibitor], necitumumab [Epidermal growth factor receptor erbB1 inhibitor], osimertinib [Epidermal growth factor receptor erbB1 inhibitor], osimertinib mesylate [Epidermal growth factor receptor erbB1 inhibitor]
JAK1	Rheumatoid Arthritis	2	baricitinib [Tyrosine-protein kinase JAK1 inhibitor], tofacitinib citrate [Janus Kinase (JAK) inhibitor], upadacitinib [Janus Kinase (JAK) inhibitor]
JAK2	Rheumatoid Arthritis	3	baricitinib [Tyrosine-protein kinase JAK2 inhibitor], tofacitinib citrate [Janus Kinase (JAK) inhibitor], upadacitinib [Janus Kinase (JAK) inhibitor]
ESR1	Postmenopausal Osteoporosis	4	bazedoxifene acetate [Estrogen receptor modulator], estradiol cypionate [Estrogen receptor alpha agonist], estrogens conjugated [Estrogen receptor agonist]
SRC	Chronic Myelogenous Leukemia	5	bosutinib [Tyrosine-protein kinase SRC inhibitor]
EGFR	Head And Neck Carcinoma	6	cetuximab [Epidermal growth factor receptor erbB1 inhibitor]
EGFR	Head And Neck Malignant Neoplasia	6	cetuximab [Epidermal growth factor receptor erbB1 inhibitor]
EGFR	Head And Neck Squamous Cell Carcinoma	6	cetuximab [Epidermal growth factor receptor erbB1 inhibitor]
EGFR	Malignant Tumor Of Neck	6	cetuximab [Epidermal growth factor receptor erbB1 inhibitor]
EGFR	Squamous Cell Carcinoma	6	cetuximab [Epidermal growth factor receptor erbB1 inhibitor]
EGFR	Colorectal Adenocarcinoma	7	cetuximab [Epidermal growth factor receptor erbB1 inhibitor], panitumumab [Epidermal growth factor receptor erbB1 inhibitor]
EGFR	Colorectal Carcinoma	7	cetuximab [Epidermal growth factor receptor erbB1 inhibitor], panitumumab [Epidermal growth factor receptor erbB1 inhibitor]
ESR1	Hemorrhage	8	clomiphene citrate [Estrogen receptor alpha modulator]
ESR1	Infertility	8	clomiphene citrate [Estrogen receptor alpha modulator]
ESR1	Polycystic Ovary Syndrome	8	clomiphene citrate [Estrogen receptor alpha modulator]
IFNG	Primary Hemophagocytic Lymphohistiocytosis	9	emapalumab [Interferon gamma inhibitor]
ESR1	Pregnancy	10	estetrol [Estrogen receptor agonist]
ESR1	Hypogonadism	11	estradiol [Estrogen receptor alpha agonist], estradiol cypionate [Estrogen receptor alpha agonist], estradiol valerate [Estrogen receptor alpha agonist], estrogens conjugated [Estrogen receptor agonist], estrogens esterified [Estrogen receptor agonist], estropipate [Estrogen receptor alpha agonist]
ESR1	Dyspareunia	12	estradiol [Estrogen receptor alpha agonist], estradiol cypionate [Estrogen receptor alpha agonist], estrogens conjugated [Estrogen receptor agonist], ospemifene [Estrogen receptor modulator]
ESR1	Premature Ovarian Insufficiency	13	estradiol [Estrogen receptor alpha agonist], estradiol valerate [Estrogen receptor alpha agonist]
ESR1	Atrophy	14	estradiol acetate [Estrogen receptor alpha agonist], estradiol cypionate [Estrogen receptor alpha agonist], estradiol valerate [Estrogen receptor alpha agonist], estrogens conjugated [Estrogen receptor agonist], estrogens conjugated synthetic a [Estrogen receptor agonist], estrogens esterified [Estrogen receptor agonist], estropipate [Estrogen receptor alpha agonist], ospemifene [Estrogen receptor modulator], synthetic conjugated estrogens b [Estrogen receptor agonist]
ESR1	Menopause	14	estradiol acetate [Estrogen receptor alpha agonist], estradiol cypionate [Estrogen receptor alpha agonist], estradiol valerate [Estrogen receptor alpha agonist], estrogens conjugated [Estrogen receptor agonist], estrogens conjugated synthetic a [Estrogen receptor agonist], estrogens esterified [Estrogen receptor agonist], estropipate [Estrogen receptor alpha agonist], ospemifene [Estrogen receptor modulator], synthetic conjugated estrogens b [Estrogen receptor agonist]
ESR1	Primary Ovarian Insufficiency	15	estradiol cypionate [Estrogen receptor alpha agonist], estradiol valerate [Estrogen receptor alpha agonist], estrogens conjugated [Estrogen receptor agonist], estrogens esterified [Estrogen receptor agonist], estropipate [Estrogen receptor alpha agonist]
ESR1	Postmenopausal Atrophic Vaginitis	16	estradiol cypionate [Estrogen receptor alpha agonist], estrogens conjugated [Estrogen receptor agonist]
ESR1	Osteoporosis	17	estradiol cypionate [Estrogen receptor alpha agonist], estrogens conjugated [Estrogen receptor agonist], estropipate [Estrogen receptor alpha agonist]
ESR1	Menorrhagia	18	estradiol valerate [Estrogen receptor alpha agonist]
ESR1	Acne	19	ethinyl estradiol [Estrogen receptor alpha agonist]
JAK2	Myelofibrosis	20	fedratinib hydrochloride [Tyrosine-protein kinase JAK2 inhibitor], ruxolitinib phosphate [Tyrosine-protein kinase JAK2 inhibitor]
JAK2	Primary Myelofibrosis	20	fedratinib hydrochloride [Tyrosine-protein kinase JAK2 inhibitor], ruxolitinib phosphate [Tyrosine-protein kinase JAK2 inhibitor]
ESR1	Breast Carcinoma	21	fulvestrant [Estrogen receptor antagonist], tamoxifen citrate [Estrogen receptor alpha modulator], toremifene citrate [Estrogen receptor modulator]
EGFR	Breast Carcinoma	22	lapatinib ditosylate [Epidermal growth factor receptor erbB1 inhibitor], neratinib maleate [Epidermal growth factor receptor erbB1 inhibitor]
LCK	Chromophobe Renal Cell Carcinoma	23	pazopanib hydrochloride [Tyrosine-protein kinase LCK inhibitor]
LCK	Clear Cell Renal Carcinoma	23	pazopanib hydrochloride [Tyrosine-protein kinase LCK inhibitor]
LCK	Collecting Duct Carcinoma	23	pazopanib hydrochloride [Tyrosine-protein kinase LCK inhibitor]
LCK	Papillary Renal Cell Carcinoma	23	pazopanib hydrochloride [Tyrosine-protein kinase LCK inhibitor]
LCK	Renal Cell Carcinoma	23	pazopanib hydrochloride [Tyrosine-protein kinase LCK inhibitor]
LCK	Sarcoma	23	pazopanib hydrochloride [Tyrosine-protein kinase LCK inhibitor]
LCK	Soft Tissue Sarcoma	23	pazopanib hydrochloride [Tyrosine-protein kinase LCK inhibitor]
JAK1	Myelofibrosis	24	ruxolitinib phosphate [Tyrosine-protein kinase JAK1 inhibitor]
JAK1	Polycythemia Vera	24	ruxolitinib phosphate [Tyrosine-protein kinase JAK1 inhibitor]
JAK1	Primary Myelofibrosis	24	ruxolitinib phosphate [Tyrosine-protein kinase JAK1 inhibitor]
JAK2	Polycythemia Vera	25	ruxolitinib phosphate [Tyrosine-protein kinase JAK2 inhibitor]
KRAS	Non-Small Cell Lung Carcinoma	26	sotorasib [GTPase KRas inhibitor]
SRC	Actinic Keratosis	27	tirbanibulin [Tyrosine-protein kinase SRC inhibitor]
TYK2	Psoriatic Arthritis	28	tofacitinib citrate [Janus Kinase (JAK) inhibitor]
JAK2	Psoriatic Arthritis	28	tofacitinib citrate [Janus Kinase (JAK) inhibitor]
JAK1	Psoriatic Arthritis	28	tofacitinib citrate [Janus Kinase (JAK) inhibitor]
TYK2	Rheumatoid Arthritis	29	tofacitinib citrate [Janus Kinase (JAK) inhibitor], upadacitinib [Janus Kinase (JAK) inhibitor]
EGFR	Medullary Thyroid Gland Carcinoma	30	vandetanib [Epidermal growth factor receptor inhibitor]
EGFR	Papillary Thyroid Carcinoma	30	vandetanib [Epidermal growth factor receptor inhibitor]
EGFR	Thyroid Carcinoma	30	vandetanib [Epidermal growth factor receptor inhibitor]
SRC	Medullary Thyroid Gland Carcinoma	31	vandetanib [Tyrosine-protein kinase SRC inhibitor]
SRC	Papillary Thyroid Carcinoma	31	vandetanib [Tyrosine-protein kinase SRC inhibitor]
SRC	Thyroid Carcinoma	31	vandetanib [Tyrosine-protein kinase SRC inhibitor]